Tianda Pharmaceuticals Limited (0455.HK) HKSE

0.13

+0(+0.00%)

Updated at November 13 02:37PM

Currency In HKD

Valuation

Market Cap363.36M
Enterprise Value405.11M
P/E Ratio-4.37
PEG Ratio0.15
Price/Sales Ratio0.81
Price/Book Ratio0.53
Enterprise/Revenue0.94
Enterprise/EBITDA-8.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.19
Operating Margin-0.17

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.12

Income Statement

Revenue329.94M
Revenue/Share0.15
Gross Profit152.02M
EBITDA-49.49M
Net Income-61.37M
Diluted EPS-0.03

Balance Sheet

Total Cash85.69M
Total Cash/Share0.04
Total Debt127.45M
Total Debt/Equity0.25
Current Ratio0.86
Book Value Per Share0.24

Price History

52-Week Change-33.86
52-Week High0.22
52-Week Low0.12
Moving Average 50 Days0.15
Moving Average 200 Days0.16

Statistics

Average Volume68,263
Shares Outstanding2.15B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.04
Last Split Factor1447:1000
Last Split DateJuly 08, 2010